Keywords: celgene, boosted, thalidomide, data, corp, positive, trial

Celgene boosted on thalidomide data

Article | 24 November 1999

Print This

Celgene Corp has had positive data from a trial of its drug Thalomid(thalidomide) in treating multiple myeloma published in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in